106.7K XNAS Volume
XNAS 19 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Cynthia Lynn Anderson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 2.51 per share. | 31 Dec 2024 | 2,592 | 6,184 (0%) | 0% | 2.5 | 6,499 | Common Stock |
| Joshua S. Prince | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 2.51 per share. | 31 Dec 2024 | 3,310 | 5,981 (0%) | 0% | 2.5 | 8,300 | Common Stock |
| Jon S. Saxe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| Ann M. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| Joanne Curley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| Mary L. Rotunno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 2.96 per share. | 28 Jun 2024 | 4,854 | 10,487 (0%) | 0% | 3.0 | 14,358 | Common Stock |
| Reid G. Adler | CHF CORP DEVEL OFF, GEN COUNS | Grant, award, or other acquisition of securities at price $ 2.96 per share. | 28 Jun 2024 | 4,854 | 16,509 (0%) | 0% | 3.0 | 14,358 | Common Stock |
| Cynthia Lynn Anderson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 2.96 per share. | 28 Jun 2024 | 3,592 | 3,592 (0%) | 0% | 3.0 | 10,625 | Common Stock |
| Joshua S. Prince | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 2.96 per share. | 28 Jun 2024 | 2,671 | 2,671 (0%) | 0% | 3.0 | 7,901 | Common Stock |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Reid G. Adler | CHF CORP DEVEL OFF, GEN COUNS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Cynthia Lynn Anderson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Joshua S. Prince | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Ann Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Joanne Curley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Mary L. Rotunno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Adler Reid G. | CHF CORP DEVEL OFF, GEN COUNS | Grant, award, or other acquisition of securities at price $ 1.72 per share. | 29 Dec 2023 | 167 | 11,655 (0%) | 0% | 1.7 | 287 | Common Stock |
| Singh K. Shawn | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 1.72 per share. | 29 Dec 2023 | 167 | 5,633 (0%) | 0% | 1.7 | 287 | Common Stock |
| Cynthia Lynn Anderson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2023 | 8,333 | 8,333 | - | - | Stock Option (right to buy) | |
| Jerrold D. Dotson | VP, CFO | Grant, award, or other acquisition of securities at price $ 1.59 per share. | 30 Jun 2023 | 167 | 3,671 (0%) | 0% | 1.6 | 265 | Common Stock |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 1.59 per share. | 30 Jun 2023 | 167 | 5,466 (0%) | 0% | 1.6 | 265 | Common Stock |
| Reid G. Adler | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 1.59 per share. | 30 Jun 2023 | 167 | 11,488 (0%) | 0% | 1.6 | 265 | Common Stock |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.09 per share. | 30 Dec 2022 | 5,000 | 105,111 (0%) | 0% | 0.1 | 438 | Common Stock |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.09 per share. | 30 Dec 2022 | 5,000 | 158,998 (0%) | 0% | 0.1 | 438 | Common Stock |
| Jerry B. Gin | Director | Purchase of securities on an exchange or from another person at price $ 0.18 per share. | 18 Aug 2022 | 100,000 | 100,000 (0%) | 0% | 0.2 | 17,870 | Common Stock |
| Jerry B. Gin | Director | Purchase of securities on an exchange or from another person at price $ 0.18 per share. | 18 Aug 2022 | 100,000 | 100,000 (0%) | 0% | 0.2 | 17,870 | Common Stock |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 0.17 per share. | 17 Aug 2022 | 600,000 | 626,234 (1%) | 1% | 0.2 | 103,200 | Common Stock |
| Reid G. Adler | CHIEF LEGAL OFFICER | Purchase of securities on an exchange or from another person at price $ 0.17 per share. | 17 Aug 2022 | 300,000 | 334,629 (0%) | 0% | 0.2 | 50,910 | Common Stock |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.75 per share. | 30 Jun 2022 | 5,000 | 100,111 (0%) | 0% | 0.7 | 3,740 | Common Stock |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.75 per share. | 30 Jun 2022 | 5,000 | 153,998 (0%) | 0% | 0.7 | 3,740 | Common Stock |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.75 per share. | 30 Jun 2022 | 5,000 | 19,915 (0%) | 0% | 0.7 | 3,740 | Common Stock |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 12 May 2022 | 100,000 | 148,998 (0%) | 0% | 1 | 100,000 | Common Stock |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2022 | 100,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Reid G. Adler | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 200,000 | 200,000 | - | - | Stock Options (right to buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Ann Cunningham | Director, CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Joanne Curley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Mary L. Rotunno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2022 | 18,750 | 15,625 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 11 Jan 2022 | 18,750 | 94,571 (0%) | 0% | 1 | 18,750 | Common Stock |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Aug 2021 | 1,111 | 61,335 (0%) | 0% | 0 | Common Stock | |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Aug 2021 | 740 | 33,901 (0%) | 0% | 0 | Common Stock | |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Purchase of securities on an exchange or from another person at price $ 2.73 per share. | 17 Aug 2021 | 3,750 | 34,641 (0%) | 0% | 2.7 | 10,238 | Common Stock |
| Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Mary L. Rotunno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 1.95 per share. | 30 Jun 2021 | 3,044 | 13,044 (0%) | 0% | 1.9 | 5,925 | Common Stock |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 30 Jun 2021 | 1,000 | 14,044 (0%) | 0% | 1.5 | 1,500 | Common Stock |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 30 Jun 2021 | 78,918 | 92,962 (0%) | 0% | 1 | 78,918 | Common Stock |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.40 per share. | 30 Jun 2021 | 9,824 | 102,786 (0%) | 0% | 0.4 | 3,910 | Common Stock |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2021 | 1,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2021 | 36,707 | 113,293 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2021 | 78,918 | 34,375 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2021 | 9,824 | 140,176 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 1.95 per share. | 30 Jun 2021 | 5,000 | 45,375 (0%) | 0% | 1.9 | 9,733 | Common Stock |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 1.95 per share. | 30 Jun 2021 | 3,391 | 91,115 (0%) | 0% | 1.9 | 6,601 | Common Stock |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 1.95 per share. | 30 Jun 2021 | 2,260 | 12,260 (0%) | 0% | 1.9 | 4,399 | Common Stock |
| Ann Cunningham | Director, CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2021 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Apr 2021 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 23 Apr 2021 | 5,000 | 40,375 (0%) | 0% | 1.5 | 7,500 | Common Stock |
| Joanne Curley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2021 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 19 Mar 2021 | 2,500 | 5,751 (0%) | 0% | 1.5 | 3,750 | Common Stock |
| Brian J. Underdown | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 19 Mar 2021 | 2,500 | 2,500 (0%) | 0% | 1.5 | 3,750 | Common Stock |
| Brian J. Underdown | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2021 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Mark J. Ginski | SENIOR VP, HEAD OF CMC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 200,000 | 200,000 | - | - | Stock Options (Right to Buy) | |
| Jon S. Saxe | Director | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 21 Aug 2020 | 30,000 | 50,000 (0%) | 0% | 0.7 | 20,700 | Common Stock |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.45 per share. | 30 Jun 2020 | 5,000 | 5,000 (0%) | 0% | 0.4 | 2,240 | Common Stock |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.45 per share. | 30 Jun 2020 | 5,000 | 30,375 (0%) | 0% | 0.4 | 2,240 | Common Stock |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.45 per share. | 30 Jun 2020 | 5,000 | 67,724 (0%) | 0% | 0.4 | 2,240 | Common Stock |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.45 per share. | 30 Jun 2020 | 5,000 | 5,000 (0%) | 0% | 0.4 | 2,240 | Common Stock |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Mark A. McPartland | VP CORPORATE DEVELOPMENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Ann Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Purchase of securities on an exchange or from another person at price $ 0.34 per share. | 20 Nov 2019 | 15,000 | 15,000 (0%) | 0% | 0.3 | 5,100 | Common Stock |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2019 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2019 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2019 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2019 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2019 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Mark A. McPartland | VP CORPORATE DEVELOPMENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2019 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2019 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2019 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Ann Cunningham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2019 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Mark A. McPartland | VP CORPORATE DEVELOPMENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Ann Cunningham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 13 Mar 2019 | 12,080 | 12,080 (0%) | 0% | 1.3 | 15,201 | Common Stock |
| Jon S. Saxe | None | Purchase of securities on an exchange or from another person at price $ 1.27 per share. | 13 Mar 2019 | 7,920 | 20,000 (0%) | 0% | 1.3 | 10,086 | Common Stock |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2019 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 13 Mar 2019 | 2,500 | 62,724 (0%) | 0% | 1.5 | 3,750 | Common Stock |
| Jon S. Saxe | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2019 | 1,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2019 | 375 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 29 Jan 2019 | 1,000 | 3,251 (0%) | 0% | 1.5 | 1,500 | Common Stock |
| Jon S. Saxe | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 29 Jan 2019 | 375 | 2,251 (0%) | 0% | 1.5 | 563 | Common Stock |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 14 Jan 2019 | 21,250 | 21,250 (0%) | 0% | 1.5 | 31,875 | Common Stock |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2019 | 3,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2019 | 1,125 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2019 | 21,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 14 Jan 2019 | 3,000 | 25,375 (0%) | 0% | 1.5 | 4,500 | Common Stock |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2019 | 220,000 | 220,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 14 Jan 2019 | 1,125 | 22,375 (0%) | 0% | 1.5 | 1,688 | Common Stock |
| Ann Cunningham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2019 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 1,000 | 1,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 2,500 | 2,500 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 375 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 7,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 35,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 1,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 375 | 375 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 1,125 | 1,125 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 21,250 | 21,250 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 3,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 1,125 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 21,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 200,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 175,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 3,000 | 3,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 678 | 678 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 1,000 | 1,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 4,323 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 75,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 678 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 1,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 4,323 | 4,323 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 1,250 | 1,250 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 12,500 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 80,000 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 1,250 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 2,500 | 2,500 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 500 | 500 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 2,500 | 2,500 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 6,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 35,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 500 | 0 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 6,250 | 6,250 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Mark A. McPartland | VP CORPORATE DEVELOPMENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Mark A. McPartland | VP CORPORATE DEVELOPMENT | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Mark A. McPartland | VP CORPORATE DEVELOPMENT | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Mark A. McPartland | VP CORPORATE DEVELOPMENT | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 40,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Mark A. McPartland | VP CORPORATE DEVELOPMENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Mark A. McPartland | VP CORPORATE DEVELOPMENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 100,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 180,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 80,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2018 | 35,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2018 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2018 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2018 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2018 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2018 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Mark A. McPartland | VP CORPORATE DEVELOPMENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2018 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2018 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2018 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2018 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2018 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2018 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2018 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2018 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Mark A. McPartland | VP CORPORATE DEVELOPMENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2018 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2018 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2018 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2017 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2017 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2017 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2017 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2017 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2017 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2017 | 25,000 | 25,000 | - | - | Warrant | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2017 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Sep 2017 | 25,000 | 0 | - | - | Warrant | |
| Jerry B. Gin | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Sep 2017 | 25,000 | 0 | - | - | Warrant | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2017 | 25,000 | 25,000 | - | - | Warrants | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2017 | 25,000 | 25,000 | - | - | Warrant | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2017 | 25,000 | 25,000 | - | - | Warrant | |
| Jerry B. Gin | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 May 2017 | 50,000 | 100,000 (1%) | 0% | 0 | Common Stock | |
| Jerry B. Gin | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 May 2017 | 25,000 | 25,000 | - | - | Warrant | |
| Jerry B. Gin | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 May 2017 | 25,000 | 50,000 | - | - | Warrant | |
| Jerry B. Gin | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 May 2017 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Jerrold D. Dotson | CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2017 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2017 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2017 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2017 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2017 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2017 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2017 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2016 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2016 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2016 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2016 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2016 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2016 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2016 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2016 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2016 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2016 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2016 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2016 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Mark Alan Smith | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2016 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Jerry B. Gin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2016 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Other type of transaction at price $ 0.00 per share. | 19 Mar 2014 | 65,000 | 65,000 | - | - | Warrant | |
| Jerrold D. Dotson | CFO AND SECRETARY | Other type of transaction at price $ 0.00 per share. | 19 Mar 2014 | 100,000 | 100,000 | - | - | Warrant | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Other type of transaction at price $ 0.00 per share. | 19 Mar 2014 | 150,000 | 150,000 | - | - | Warrant | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Other type of transaction at price $ 0.00 per share. | 19 Mar 2014 | 50,000 | 50,000 | - | - | Warrant | |
| Brian J. Underdown | None | Other type of transaction at price $ 0.00 per share. | 19 Mar 2014 | 50,000 | 50,000 | - | - | Warrant for Common Stock | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 150,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 7,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 50,000 | 50,000 | - | - | Warrant for Common Stock | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 50,000 | 0 | - | - | Warrant for Common Stock | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 50,000 | 0 | - | - | Warrant | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 35,714 | 0 | - | - | Warrant | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 80,338 | 80,338 | - | - | Warrant | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 100,000 | 100,000 | - | - | Common Stock | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 35,714 | 35,714 | - | - | Warrant | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 80,338 | 0 | - | - | Warrant | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 50,000 | 50,000 | - | - | Warrant | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 40,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 1,000,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 425,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 1,000,000 | 1,000,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 425,000 | 425,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 22,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 100,000 | 100,000 | - | - | Warrant | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 6,251 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 86,459 | 86,459 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 86,459 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 6,249 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 13,541 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 13,541 | 13,541 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 6,249 | 6,249 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 1,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 6,251 | 6,251 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 1,000 | 1,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 150,000 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 250,000 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 50,000 | 0 | - | - | Warrant for Common Stock | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 50,000 | 50,000 | - | - | Warrant for Common Stock | |
| Brian J. Underdown | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Dec 2013 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2013 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2013 | 10,000 | 312,174 | - | - | Common Stock | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2013 | 10,000 | 1,440,000 | - | - | Warrant | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2013 | 50,000 | 302,174 | - | - | Common Stock | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2013 | 50,000 | 1,450,000 | - | - | Warrant | |
| Jon S. Saxe | None | Other type of transaction at price $ 0.00 per share. | 03 Mar 2013 | 150,000 | 150,000 | - | - | Warrant | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Other type of transaction at price $ 0.00 per share. | 03 Mar 2013 | 1,500,000 | 1,500,000 | - | - | Warrant | |
| Jerrold D. Dotson | CFO | Other type of transaction at price $ 0.00 per share. | 03 Mar 2013 | 200,000 | 200,000 | - | - | Warrant | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Other type of transaction at price $ 0.00 per share. | 03 Mar 2013 | 1,000,000 | 1,000,000 | - | - | Warrant | |
| Brian J. Underdown | None | Other type of transaction at price $ 0.00 per share. | 03 Mar 2013 | 150,000 | 150,000 | - | - | Warrant | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2012 | 50,000 | 50,000 | - | - | Warrant | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2012 | 100,000 | 252,174 | - | - | Common Stock | |
| Jerrold D. Dotson | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2012 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2012 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2012 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2012 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Jerrold D. Dotson | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2012 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| A. Franklin Rice | VP CORPORATE DEVELOPMENT | Gift of securities by or to the insider at price $ 0.00 per share. | 03 May 2012 | 50,000 | 174,046 | - | - | Common Stock | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2012 | 50,000 | 0 | - | - | Warrant for Common Stock | |
| Gregory A. Bonfiglio | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2012 | 50,000 | 50,000 | - | - | Warrant for Common Stock | |
| Brian J. Underdown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2012 | 50,000 | 50,000 | - | - | Warrant for Common Stock | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2011 | 113,636 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | Director, PRES./CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2011 | 113,636 | 1,204,468 | - | - | Common Stock | |
| Cato Easley Allen | Ten Percent Owner | 15 Dec 2011 | 11,363 | 28,497 | - | - | Common Stock | ||
| Cato Easley Allen | Ten Percent Owner | 15 Dec 2011 | 11,363 | 28,067 | - | - | Warrant | ||
| Cato Easley Allen | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Dec 2011 | 6,988 | 28,067 | - | - | Warrant | |
| Cato Easley Allen | Ten Percent Owner | 15 Dec 2011 | 212,166 | 0 | - | - | Warrant | ||
| Cato Easley Allen | Ten Percent Owner | 15 Dec 2011 | 2,916 | 0 | - | - | Warrant | ||
| Cato Easley Allen | Ten Percent Owner | 15 Dec 2011 | 46,542 | 0 | - | - | Warrant | ||
| Cato Easley Allen | Ten Percent Owner | 15 Dec 2011 | 162,500 | 0 | - | - | Warrant | ||
| Jerrold D. Dotson | ACTING CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2011 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| A. Franklin Rice | CHIEF OPERATING OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Aug 2011 | 219,000 | 240,046 | - | - | Common Stock | |
| A. Franklin Rice | CHIEF OPERATING OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Aug 2011 | 16,000 | 224,046 | - | - | Common Stock | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 1,250 | 1,250 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 4,375 | 4,375 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 3,000 | 3,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 2,500 | 2,500 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 3,750 | 3,750 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 3,750 | 3,750 | - | - | Stock Optioin (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 75,000 | 75,000 | - | - | Stock Optioin (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 1,392 | 1,392 | - | - | Warrant | |
| Jon S. Saxe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 17,354 | 17,354 | - | - | Common Stock | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 11,250 | 11,250 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 212,500 | 212,500 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 750 | 750 | - | - | Warrant | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 40,169 | 40,169 | - | - | Warrant | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 17,857 | 17,857 | - | - | Warrant | |
| Shawn K. Singh | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 76,087 | 76,087 | - | - | Common Stock | |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 545,416 | 545,416 | - | - | Common Stock | |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 56,818 | 56,818 | - | - | Stock Option (Right to Buy) | |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 3,181 | 3,181 | - | - | Stock Option (Right to Buy) | |
| A. Franklin Rice | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 229,521 | 229,521 | - | - | Common Stock | |
| A. Franklin Rice | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 1,428 | 1,428 | - | - | Warrant | |
| A. Franklin Rice | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 5,500 | 5,500 | - | - | Stock Option (Right to Buy) | |
| A. Franklin Rice | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 6,250 | 6,250 | - | - | Stock Option (Right to Buy) | |
| A. Franklin Rice | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| A. Franklin Rice | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| A. Franklin Rice | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 12,500 | 12,500 | - | - | Stock Optioin (Right to Buy) | |
| A. Franklin Rice | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| A. Franklin Rice | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| A. Franklin Rice | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| A. Franklin Rice | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| A. Franklin Rice | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| A. Franklin Rice | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 795 | 795 | - | - | Warrant | |
| Stephanie Jones | Director, PRESIDENT, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 May 2011 | 4,982,103 | 17,897 | - | - | Common Stock |